These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1441 related items for PubMed ID: 12529172
1. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity. Bardwell AJ, Abdollahi M, Bardwell L. Biochem J; 2003 Mar 15; 370(Pt 3):1077-85. PubMed ID: 12529172 [Abstract] [Full Text] [Related]
2. A conserved docking site in MEKs mediates high-affinity binding to MAP kinases and cooperates with a scaffold protein to enhance signal transmission. Bardwell AJ, Flatauer LJ, Matsukuma K, Thorner J, Bardwell L. J Biol Chem; 2001 Mar 30; 276(13):10374-86. PubMed ID: 11134045 [Abstract] [Full Text] [Related]
3. A docking site in MKK4 mediates high affinity binding to JNK MAPKs and competes with similar docking sites in JNK substrates. Ho DT, Bardwell AJ, Abdollahi M, Bardwell L. J Biol Chem; 2003 Aug 29; 278(35):32662-72. PubMed ID: 12788955 [Abstract] [Full Text] [Related]
5. Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo. Grewal S, Molina DM, Bardwell L. Cell Signal; 2006 Jan 29; 18(1):123-34. PubMed ID: 15979847 [Abstract] [Full Text] [Related]
7. MEK1 and the extracellular signal-regulated kinases are required for the stimulation of IL-2 gene transcription in T cells. Whitehurst CE, Geppert TD. J Immunol; 1996 Feb 01; 156(3):1020-9. PubMed ID: 8557975 [Abstract] [Full Text] [Related]
8. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells. Reffas S, Schlegel W. Biochem J; 2000 Dec 15; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676 [Abstract] [Full Text] [Related]
9. Distinct binding determinants for ERK2/p38alpha and JNK map kinases mediate catalytic activation and substrate selectivity of map kinase phosphatase-1. Slack DN, Seternes OM, Gabrielsen M, Keyse SM. J Biol Chem; 2001 May 11; 276(19):16491-500. PubMed ID: 11278799 [Abstract] [Full Text] [Related]
11. p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression. Westermarck J, Li SP, Kallunki T, Han J, Kähäri VM. Mol Cell Biol; 2001 Apr 11; 21(7):2373-83. PubMed ID: 11259586 [Abstract] [Full Text] [Related]
12. A docking site determining specificity of Pbs2 MAPKK for Ssk2/Ssk22 MAPKKKs in the yeast HOG pathway. Tatebayashi K, Takekawa M, Saito H. EMBO J; 2003 Jul 15; 22(14):3624-34. PubMed ID: 12853477 [Abstract] [Full Text] [Related]
13. Catalytic activation of mitogen-activated protein (MAP) kinase phosphatase-1 by binding to p38 MAP kinase: critical role of the p38 C-terminal domain in its negative regulation. Hutter D, Chen P, Barnes J, Liu Y. Biochem J; 2000 Nov 15; 352 Pt 1(Pt 1):155-63. PubMed ID: 11062068 [Abstract] [Full Text] [Related]
14. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. Wu W, Pew T, Zou M, Pang D, Conzen SD. J Biol Chem; 2005 Feb 11; 280(6):4117-24. PubMed ID: 15590693 [Abstract] [Full Text] [Related]